Biotech Currents

Biotech Currents

Share this post

Biotech Currents
Biotech Currents
Two Syndax drugs may receive FDA approvals later this year in graft v host & leukemia | $SNDX

Two Syndax drugs may receive FDA approvals…

Bill Langbein
Apr 22, 2024

Share this post

Biotech Currents
Biotech Currents
Two Syndax drugs may receive FDA approvals later this year in graft v host & leukemia | $SNDX

This thread is only visible to paid subscribers of Biotech Currents

Subscribe to view →

Comments on this post are for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bill Langbein
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share